Using Samsung Galaxy to detect obstructive sleep apnea
Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea
This study is testing if the Samsung Galaxy Watch can accurately detect moderate to severe sleep apnea in adults who have it or are at high risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 22 Years and up |
| Sex | All |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Trial ID | NCT06603441 on ClinicalTrials.gov |
What this trial studies
This study evaluates the reliability of the Samsung Galaxy Watch in detecting moderate to severe obstructive sleep apnea (OSA) in adults. A cohort of 150 individuals aged 22 and older, either diagnosed with OSA or at high risk, will be monitored using the watch's technology to track sleep patterns, oxygen saturation, and heart rate variability. Participants will undergo assessments in a sleep lab and at home over several nights to gather comprehensive data on their sleep health.
Who should consider this trial
Good fit: Ideal candidates are adults aged 22 and older with a prior diagnosis or high likelihood of moderate to severe obstructive sleep apnea.
Not a fit: Patients with severe acute medical illnesses, active comorbid sleep disorders, or unstable psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive and accessible method for detecting obstructive sleep apnea, improving diagnosis and management for patients.
How similar studies have performed: Other studies have explored wearable technology for sleep apnea detection, showing promising results, but this specific approach with the Samsung Galaxy is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 22 years of age or older * High pre-test likelihood of moderate to severe obstructive sleep apnea (OSA) based on screening questionnaires (STOP-Bang and Epworth Sleepiness Scale); or prior diagnosis of moderate-severe OSA. * Able to provide informed consent confirmation Exclusion Criteria: * Severe and/or other acute medical illnesses as determined by the Investigator, in particular: Cardiac conditions such as Congestive Heart Failure (CHF), atrial fibrillation, Hx of Movement disorders: Parkinson's, Tremor, Lung conditions: Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, emphysema, pulmonary fibrosis, acute episode of flu, allergies, asthma. * Active comorbid sleep disorders, such as severe insomnia, restless legs syndrome, Periodic Leg Movement During Sleep (PLMS), narcolepsy, idiopathic hypersomnia * Severe and/or unstable psychiatric disorders such as mood, anxiety, or psychotic disorders * Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk * Inability to use a Samsung Galaxy device for sleep tracking * Inability to have two nights in the Stanford sleep lab. * Participants who are pregnant * Tattoos or scars covering the forearm area of both hands
Where this trial is running
Palo Alto, California
- Stanford University — Palo Alto, California, United States (Recruiting)
Study contacts
- Principal investigator: Robson Capasso, MD — Stanford University
- Study coordinator: Robson Capasso, MD
- Email: rcapasso@stanford.edu
- Phone: (650) 724-5994
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.